Pharmacist assessment of drug-gene interactions and drug-induced phenoconversion in major depressive disorder: a case report

BACKGROUND: Response to antidepressant therapy is highly variable among individuals. Pharmacogenomic (PGx) testing presents an opportunity to guide drug selection while optimizing therapy outcomes and/or decreasing the risk for toxicity. CASE PRESENTATION: A patient with multiple comorbidities, incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Toro-Pagán, N. M., Matos, A., Bardolia, C., Michaud, V., Turgeon, J., Amin, N. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772164/
https://www.ncbi.nlm.nih.gov/pubmed/35057765
http://dx.doi.org/10.1186/s12888-021-03659-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772164/
https://www.ncbi.nlm.nih.gov/pubmed/35057765
http://dx.doi.org/10.1186/s12888-021-03659-4

Ejemplares similares